MannKind Corp
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve… Read more
MannKind Corp (MNKD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.527x
Based on the latest financial reports, MannKind Corp (MNKD) has a cash flow conversion efficiency ratio of -0.527x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($23.49 Million) by net assets ($-44.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MannKind Corp - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how MannKind Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MannKind Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MannKind Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kiatnakin Bank Public Company. Ltd
OTCGREY:KNFSF
|
0.085x |
|
Lovisa Holdings Ltd
AU:LOV
|
1.157x |
|
Viglacera Corp JSC
VN:VGC
|
0.209x |
|
Shanghai Feilo Acoustics Co Ltd
SHG:600651
|
0.054x |
|
GemVax&KAEL Co.Ltd
KQ:082270
|
0.001x |
|
Tianneng Battery Group Co Ltd
SHG:688819
|
0.063x |
|
Bic Camera Inc
F:1U3
|
N/A |
|
Xiamen Meiya Pico Information
SHE:300188
|
-0.013x |
Annual Cash Flow Conversion Efficiency for MannKind Corp (2002–2024)
The table below shows the annual cash flow conversion efficiency of MannKind Corp from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-78.82 Million | $42.51 Million | -0.539x | -289.44% |
| 2023-12-31 | $-246.17 Million | $34.09 Million | -0.138x | -143.00% |
| 2022-12-31 | $-250.54 Million | $-80.70 Million | 0.322x | +9.27% |
| 2021-12-31 | $-209.35 Million | $-61.71 Million | 0.295x | +89.07% |
| 2020-12-31 | $-180.42 Million | $-28.13 Million | 0.156x | -66.43% |
| 2019-12-31 | $-190.53 Million | $-88.48 Million | 0.464x | +115.50% |
| 2018-12-31 | $-175.08 Million | $-37.73 Million | 0.216x | -28.56% |
| 2017-12-31 | $-214.73 Million | $-64.78 Million | 0.302x | -29.08% |
| 2016-12-31 | $-183.59 Million | $-78.09 Million | 0.425x | +160.37% |
| 2015-12-31 | $-350.33 Million | $-57.23 Million | 0.163x | +394.94% |
| 2014-12-31 | $-73.77 Million | $4.09 Million | -0.055x | -101.32% |
| 2013-12-31 | $-30.71 Million | $-128.73 Million | 4.191x | +287.04% |
| 2012-12-31 | $-110.68 Million | $-119.86 Million | 1.083x | +174.29% |
| 2011-12-31 | $-313.65 Million | $-123.84 Million | 0.395x | -50.72% |
| 2010-12-31 | $-185.53 Million | $-148.65 Million | 0.801x | -74.22% |
| 2009-12-31 | $-59.22 Million | $-184.08 Million | 3.108x | +199.38% |
| 2008-12-31 | $86.73 Million | $-271.29 Million | -3.128x | -364.55% |
| 2007-12-31 | $364.10 Million | $-245.15 Million | -0.673x | -36.04% |
| 2006-12-31 | $383.49 Million | $-189.79 Million | -0.495x | -1.19% |
| 2005-12-31 | $206.98 Million | $-101.23 Million | -0.489x | -22.75% |
| 2004-12-31 | $150.36 Million | $-59.91 Million | -0.398x | +15.75% |
| 2003-12-31 | $111.58 Million | $-52.77 Million | -0.473x | +11.78% |
| 2002-12-31 | $90.77 Million | $-48.67 Million | -0.536x | -- |